ISSN: 2155-6199
Journal of Bioremediation & Biodegradation
Open Access
Bioremediation Products
Search results for
Bioremediation Products
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 7718
Journal of Bioremediation & Biodegradation received 7718 citations as per Google Scholar report
Journal of Bioremediation & Biodegradation peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- Access to Global Online Research in Agriculture (AGORA)
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Publons
- Geneva Foundation for Medical Education and Research
- MIAR
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Bioremediation Products
Alabaster Corp. Bioremediation Products for oil spill cleaning, Bio Tech, Inc. leads the industry in the use of microorganisms to improve the performance of oil & gas producing wells, SWDs and waterfloods. Biohidrica; Developer of products for the detection and control of environmental contamination.
Related Journals of Bioremediation Products
Natural Products Chemistry & Research,Journal of Molecular Pharmaceutics & Organic Process Research,Journal of Pharmacognosy & Natural Products,Journal of Natural Products,Journal of Asian Natural Products Research,Studies in Natural Products Chemistry,Records of Natural Products
Bioremediation Products
Speaker PPTs
- Dalia Sekmokiene
Antimicrobial, antioxidative, phytochemical and functional characteristics of the extracts of some plants and spices seeking to adapt them as a potential source of biologically active substances for the safety of dairy products
PPT Version | PDF Version - Alexandra Emelyanova
Released-active antibodies are innovative products for the effective management of severe respiratory viral infections
PPT Version | PDF Version - Chang-Hung Chou
Diversified natural products in Rhododendron formosanum reveal allelochemical and pharmaceutical properties
PPT Version | PDF Version - Yi-Cheng Hu
Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
PPT Version | PDF Version - Carsten Worsoe
The value of the ââ¬Åsimulated studyââ¬Â as a tool to predict actual leachables in parenteral drug products
PPT Version | PDF Version - Diane Paskiet
Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
PPT Version | PDF Version - Neervalur V Raghavan
Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
PPT Version | PDF Version - Jianfeng Hong
Extractable and leachable studies of parenteral infusion and transfusion products
PPT Version | PDF Version - Heidi Schalchli
Natural products of Anthracophyllum discolor: Ligninolytic enzymes and antifungal volatile compounds
PPT Version | PDF Version - Shree Kumar Apte
Genetic engineering of Deinococcus radiodurans for uranium bioremediation from high radiation environment
PPT Version | PDF Version - Hazel Gorham
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
PPT Version | PDF Version - Yosef Yarden
Classically, the 3ââ¬â¢untranslated region (3ââ¬â¢UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3ââ¬â¢UTR alone, without all other elements in mRNA such as 5ââ¬â¢UTR and coding region. The importance of independent 3ââ¬â¢UTR RNA (referred as I3ââ¬â¢UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3ââ¬â¢UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3ââ¬â¢UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3ââ¬â¢UTR were important for its tumor suppression activity. Then, the C/EBP 3ââ¬â¢UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3ââ¬â¢UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3ââ¬â¢UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990ââ¬â¢s to 2000ââ¬â¢s, world scientists found several 3ââ¬â¢UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3ââ¬â¢UTR regions, although the existence of their transcribed products as independent 3ââ¬â¢UTR RNAs is still to be confirmed. Our studies indicate that the independent 3ââ¬â¢UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
PPT Version | PDF Version - Hyeun-Jong Bae
Onion waste recycling to produce the value added by-products
PPT Version | PDF Version - Kazuo Yano
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
PPT Version | PDF Version - C. Diaz
New Antibacterial Agents against Gram-negative Pathogens from a Fundacion MEDINAââ¬â¢s Microbial Natural Products Collection Screening
PPT Version | PDF Version - Szabolcs Peter
Vitamin E - Emerging benefits
PPT Version | PDF Version - Daniel Raederstorff
Nutritional solutions to counteract impact of air pollution
PPT Version | PDF Version - Thomas J Franz
Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
PPT Version | PDF Version - Cemalettin Saricoban
The effects of various milk bi products on microbial properties of beef patties
PPT Version | PDF Version - Zahariah Ismail
The benefit of palm tocotrienols in personal care products
PPT Version | PDF Version - Eva Skrivanova
Alternatives to in-feed antibiotics and their impact on the safety of animal products
PPT Version | PDF Version - Mona Mohammed
Key considerations of orphan products designation and registration regulation
PPT Version | PDF Version - Harun Rasit Uysal
European and Turkish dairy sector: Traditional dairy products at a glance
PPT Version | PDF Version - Eman H.Abdel-Rahman
Induction of protective cellular and humoral responses against fasciolosis in rabbits using immunoaffinity fraction of Fasciola gigantica excretory secretory products
PPT Version | PDF Version - Osama Ibrahim
Oligosaccharides: An overview of beneficial sweeteners for food products
PPT Version | PDF Version